Brief: Maravai Lifesciences Announces CEO Leadership Transition
Oct 3 (Reuters) - Maravai LifeSciences Holdings Inc
MRVI.O :
* MARAVAI LIFESCIENCES ANNOUNCES CEO LEADERSHIP TRANSITION
* MARAVAI LIFESCIENCES HOLDINGS INC - WILLIAM "TREY" MARTIN,
III
APPOINTED TO SUCCEED CARL HULL AS CHIEF EXECUTIVE OFFICER
* MARAVAI LIFESCIENCES HOLDINGS INC - HULL TO SERVE AS
EXECUTIVE
CHAIRMAN OF BOARD OF DIRECTORS
* MARAVAI LIFESCIENCES HOLDINGS INC - MARTIN COMES TO
MARAVAI MOST
RECENTLY FROM DANAHER CORPORATION
Source text for Eikon: ID:nGNX4N5LmN
Further company coverage: MRVI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maravai Lifesciences Holdings
See all newsMaravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million